Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Is a |
Product containing chlorphenamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Is a |
Product containing phenyltoloxamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Is a |
Product containing phenylephrine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenylephrine hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chlorphenamine maleate |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine (substance) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine citrate |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cardiovascular agent (substance) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Is a |
Product containing phenylephrine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
Is a |
Chlorphenamine-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|